• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.23% Nasdaq Down0.70%

    Response Biomedical Corp. (RPBIF)

    -OTC BB
    0.34 0.00(0.00%) Sep 18
    ProfileGet Profile for:
    Response Biomedical Corp.
    1781 - 75th Avenue West
    Vancouver, BC V6P 6P2
    Canada - Map
    Phone: 604-456-6010
    Fax: 604-456-6066
    Website: http://www.responsebio.com

    Index Membership:N/A
    Full Time Employees:68

    Business Summary 

    Response Biomedical Corp. engages in the research, development, commercialization, and distribution of diagnostic technologies for the medical central-lab testing, point of care (POC) testing, and on-site environmental testing markets. The POC and on-site diagnostic tests are non-laboratory based tests performed using portable hand-held devices, compact desktop analyzers, single-use test cartridges, and/or dipsticks. It provides RAMP system, which is a portable fluorescence immunoassay-based diagnostic technology that combines the performance of a clinical lab with the convenience of a dipstick test. The company’s RAMP tests are used in the early detection of heart attack, congestive heart failure, influenza A+B, the respiratory syncytial virus, and environmental detection of West Nile Virus; and biodefense applications, including the rapid on-site detection of anthrax, smallpox, ricin, and botulinum toxin. Response Biomedical Corp. sells its products through distributors primarily in the United States, Asia, the Latin America, Europe, South America, Canada, the Middle East, and internationally. The company was founded in 1980 and is headquartered in Vancouver, Canada.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Response Biomedical Corp.

    Key Executives 
    Dr. Barbara R. Kinnaird Steen Ph.D., 48
    Chief Exec. Officer
    Mr. William J. Adams C.A., 53
    Chief Financial Officer and Corp. Sec.
    Dr. Anthony F. Holler M.D., 64
    Treasurer, Director and Member of Option Committee
    Mr. Bill Wickson ,
    Director of Investor Relations
    Mr. Anastasios Tsonis , 35
    Corp. Controller
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders